Venous Procedure Devices Market (2021 - 2031)
Venous Procedure Devices Market By Product (Venous Stents, Catheters, Guidewires), By Application (Leg, Chest, Abdomen), By Indication (Vascular Diseases, Cancer), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Region - Global Insights to 2031
Core Findings
FREE CustomizationMarket Outlook for Venous Procedure Devices
The global venous procedure devices market is projected to surpass US$ 3 billion valuation by 2031, expanding at a CAGR of around 6%, with demand for chest venous procedure devices and abdomen venous procedure devices being high. Venous procedure devices have experienced notable uptake for key cardiovascular procedures, with sales of drug-eluting stents and catheters acquiring central importance.
Surgical procedures for vascular disease indication is expected to garner significant attention, providing fertile ground for market expansion. A new report by Facr.MR tracks the global sales of the venous procedure devices market in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the healthcare domain in general, and venous procedure device demand in particular.
How Do Historical and Future Projections Compare?
Surging cardiovascular disease incidence in the past few years has greatly enhanced uptake of venous procedure devices, with prominent manufacturers introducing technologically advanced products. The market was valued at US$ 2 billion in 2019, with growth expected to incline further in upcoming years.
Prospects appeared temporarily dim during the initial months of COVID-19, as elective surgical procedures took a backseat. However, since Q4 2020, a gradual upswing with relaxation of restrictions across key healthcare domains. Future expansion will be largely influenced by increased uptake of specialized stents and catheters.
How are Technological Advancements Paving the Way for Future Market Expansion?
Several players are introducing technologically advanced products based on upgraded techniques, enabling precise and improved diagnostics to patients suffering from venous diseases. A major breakthrough in this regard is the development of a centralized administration system.
Patients often need central venous access for indications, including ongoing hemodynamic monitoring, difficult venous access, or long-term IV therapy. Numerous central venous catheters and devices are available which enable such access. Additionally, advancements such as Doppler ultrasound have enabled practitioners to effectively diagnose diseases like deep vein thrombosis and vasculitis.
Why are Clinicians Opting for Advanced Drug Eluting Venous Stents?
Stenting of arteries as a percutaneous transluminal angioplasty procedure is a promising minimally invasive therapy based on reopening narrowed arteries. Hence, prominent manufacturers are looking leverage high quality drug eluting venous stents for achieving high patient outcomes.
Drug eluting stents (DES) have been developed to overcome the main shortcomings of bare metal stents (BMS) or coated stents. Boston Scientific is boosting its marketing capabilities of Eluvia drug eluting vascular stent system, which is capable of delivering exceptional outcomes in complex lesions.
How are Product Recalls Impeding the Growth Prospects of Manufacturers?
In the recent past, several venous procedure devices have been recalled from the market due to documentation of undesired adverse patient outcomes. For instance, in 2017, Vascular Solutions Inc. recalled over 7,000 units of its venture catheters due to the presence of excess material at the tip of the catheter which separated during surgery, leading to development of blood clots.
Hence, major medical device manufacturers are subjecting each product to strict inspection and laboratory testing so as to offset any anomaly which may arise during the trials. This prolongs effective availability of key surgical devices, thereby limiting growth prospects for venous procedure devices in the long run.
Country-wise Insights
Why is the U.S. a Prominent Market for Venous Procedure Devices?
The US is expected to generate ample growth opportunities for the venous procedure devices market, attributed to increased surgical procedures for various cardiac anomalies. According to the Society for Vascular Surgery, peripheral arterial disease (PAD) affects between 8 and 12 million people in the US, while nearly 200,000 people are annually diagnosed with abdominal aortic aneurysm (AAA).
Hence, prominent healthcare companies are expected to cement their presence throughout the US market, rendering it the most lucrative country throughout North America. Prominent manufacturers include Medtronic Plc., Boston Scientific Corporation, Abbott Laboratories and Cook Medical among others.
How Will India Generate Growth Prospects for Venous Procedure Device Suppliers?
According to W.H.O, India reported 63% of total deaths due to non-communicable diseases, of which 27% were attributed to cardiovascular diseases. Hence, the scope for enhanced venous procedure device sales is increasing throughout the country in recent years.
Furthermore, ailments such as varicose veins is also prompting uptake. In 2019, Apollo Hospitals, Chennai became the first national center to perform a modern varicose vein removal surgery using the VenalSeal closure system. Such developments will greatly enhance prospects for the Indian market.
Category-wise Insights
Why is There High Demand for Venous Procedure Catheters?
By product, demand for venous procedure catheters is expected to see considerable incline, with preference for central catheters generating bulk of total demand. Central catheters are more effective in directly administering nutrition and medication directly into the bloodstream.
Central venous catheters are less likely to detach from the vein, permitting patients to remain more active and receive intravenous medication at home. Furthermore, it enables delivery of larger blood quantities to patients in severe shock.
Which is the Most Common Venous Procedure Device Application Area?
By application, chest implants are expected to remain highly utilized in the venous procedure devices domain, particularly in the infraclavicular region. This offers greater convenience to surgeons while operating on a patient.
However, abdomen venous procedure devices are also surging in popularity, attributed to increased prevalence of chronic kidney ailments requiring patients to undergo hemodialysis procedures.
Why is Vascular Disease Indication Acquiring Ground?
By indication, vascular diseases are expected to generate significant demand, amid the rising prevalence of deep vein thrombosis globally. As per the Centers for Disease Control and Prevention, approximately 900,000 people are affected by it across the US, with 10-30% succumbing within a month of diagnosis.
Treatment for hemodialysis/arteriovenous fistulae is also anticipated to incline, attributed to its surging prevalence rate in recent years.
Competitive Landscape
Notable developments with regards to key venous procedure device manufacturers are as follows:
- In May 2021, Medtronic Plc. announced designation of the CE Mark for its EvolutTM PRO+ TAVI System for treating patients with symptomatic severe aortic stenosis across Europe
- In May 2019, Cardinal Health company Cordis announced the full US launch of its RADIAL 360 portfolio for interventional cardiology purposes, comprising of four main devices
*This list is indicative- full details about prominent venous procedure devices manufacturers is available upon request.
Report Scope
| Attribute | Details |
|---|---|
| Forecast Period | 2021 to 2031 |
| Historical Data Available for | 2016 to 2020 |
| Market Analysis | US$ Mn for Value & ‘000 Units for Volume |
| Key Regions Covered | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Key Countries Covered | US, Canada, UK, Germany, France, Spain, Italy, China, India, Japan, Australia & New Zealand, GCC, South Africa, Brazil, Mexico |
| Key Segments Covered | Product, Application, Indication, End User, Region |
| Key Companies Profiled | Medtronic Plc.; Cardinal Health; Becton Dickinson & Co. (BD); Terumo Corporation; Teleflex Incorporated; Boston Scientific Corporation; Optimed Medizinische Instrumente GmbH; Cook Medical; B. Braun Melsungen AG; Abbott Laboratories |
| Customization & Pricing | Available upon Request |
Key Market Segments Covered
-
By Product :
- Venous Stents
- Drug-eluting Venous Stents
- Non-drug Eluting Venous Stents
- Venous Procedure Catheters
- Central Venous Catheters
- Subcutaneous (Implanted) Venous Port Catheters
- Peripherally Inserted Central Venous Catheters (PICC)
- Venous Procedure Guidewires
- Standard Venous Procedure Guidewires
- High Support Venous Procedure Guidewires
- Flexible Venous Procedure Guidewires
- Chronic Total Occlusion Venous Procedure Guidewires
- Others
- Venous Stents
-
By Application :
- Leg Venous Procedure Devices
- Chest Venous Procedure Devices
- Abdomen Venous Procedure Devices
- Arm Venous Procedure Devices
-
By Indication :
- Venous Procedure Devices for Vascular Diseases
- Chronic Deep Vein Thrombosis
- Post-thrombotic Syndrome
- May-Thurner Syndrome
- Hemodialysis/Arteriovenous Fistulae
- Others
- Venous Procedure Devices for Cancer
- Venous Procedure Devices for Vascular Diseases
-
By End User :
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
-
By Region :
- North America (US and Canada)
- Europe (Germany, UK, France, Italy, Spain and Rest of Europe)
- Asia-Pacific (China, Japan, India, Australia & New Zealand and Rest of Asia-Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (GCC, South Africa and Rest of MEA)
Table of Content
- 1. Preface
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Market
- 4. Market Overview
- 5. Key Insights
- 6. Global Market Analysis and Forecast, by Product
- 6.1. Venous Stents
- 6.1.1. Drug Eluting Venous Stent
- 6.1.2. Non-drug Eluting Venous Stent
- 6.2. Catheters
- 6.2.1. Central Venous Catheter
- 6.2.2. Subcutaneous (Implanted) Port
- 6.2.3. Peripherally Inserted Central Catheter (PICC)
- 6.3. Guidewires
- 6.3.1. Standard
- 6.3.2. High Support
- 6.3.3. Flexible
- 6.3.4. Chronic Total Occlusion
- 6.4. Others
- 6.1. Venous Stents
- 7. Global Market Analysis and Forecast, by Application
- 7.1. Leg
- 7.2. Chest
- 7.3. Abdomen
- 7.4. Arm
- 8. Global Market Analysis and Forecast, by Indication
- 8.1. Vascular Diseases
- 8.1.1. Chronic Deep Vein Thrombosis
- 8.1.2. Post-thrombotic Syndrome
- 8.1.3. May-Thurner Syndrome
- 8.1.4. Hemodialysis/Arteriovenous Fistulae
- 8.1.5. Others
- 8.2. Cancer
- 8.1. Vascular Diseases
- 9. Global Market Analysis and Forecast, by End User
- 9.1. Hospitals
- 9.2. Ambulatory Surgical Centers
- 9.3. Specialty Clinics
- 9.4. Others
- 10. Global Market Analysis and Forecast, by Region
- 10.1. North America
- 10.2. Europe
- 10.3. Asia Pacific
- 10.4. Latin America
- 10.5. Middle East & Africa
- 11. North America Market Analysis and Forecast
- 12. Europe Market Analysis and Forecast
- 13. Asia Pacific Market Analysis and Forecast
- 14. Latin America Market Analysis and Forecast
- 15. Middle East & Africa Market Analysis and Forecast
- 16. Competitive Landscape
- 16.1. Medtronic Plc
- 16.2. Cardinal Health
- 16.3. BD
- 16.4. Terumo Corporation
- 16.5. Teleflex Incorporated
- 16.6. Boston Scientific Corporation
- 16.7. Optimed Medizinische Instrumente GmbH
- 16.8. Cook
- 16.9. B. Braun Melsungen AG
- 16.10. Abbott
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast, by Product, 2021 to 2031
Table 02: Global Market Value (US$ Mn) Forecast, by Venous Stents, 2021 to 2031
Table 03: Global Market Value (US$ Mn) Forecast, by Catheters, 2021 to 2031
Table 04: Global Market Value (US$ Mn) Forecast, by Guidewires, 2021 to 2031
Table 05: Global Market Value (US$ Mn) Forecast, by Application, 2021 to 2031
Table 06: Global Market Value (US$ Mn) Forecast, by Indication, 2021 to 2031
Table 07: Global Market Value (US$ Mn) Forecast, by Vascular Diseases, 2021 to 2031
Table 08: Global Market Value (US$ Mn) Forecast, by End User, 2021 to 2031
Table 09: Global Market Value (US$ Mn) Forecast, by Region, 2021 to 2031
Table 10: North America Market Value (US$ Mn) Forecast, by Country, 2021 to 2031
Table 11: North America Market Value (US$ Mn) Forecast, by Product, 2021 to 2031
Table 12: North America Market Value (US$ Mn) Forecast, by Venous Stents, 2021 to 2031
Table 13: North America Market Value (US$ Mn) Forecast, by Catheters, 2021 to 2031
Table 14: North America Market Value (US$ Mn) Forecast, by Product, 2021 to 2031
Table 15: North America Market Value (US$ Mn) Forecast, by Application, 2021 to 2031
Table 16: North America Market Value (US$ Mn) Forecast, by Indication, 2021 to 2031
Table 17: North America Market Value (US$ Mn) Forecast, by Vascular Diseases, 2021 to 2031
Table 18: North America Market Value (US$ Mn) Forecast, by End User, 2021 to 2031
Table 19: Europe Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2021 to 2031
Table 20: Europe Market Value (US$ Mn) Forecast, by Product, 2021 to 2031
Table 21: Europe Market Value (US$ Mn) Forecast, by Venous Stents, 2021 to 2031
Table 22: Europe Market Value (US$ Mn) Forecast, by Catheters, 2021 to 2031
Table 23: Europe Market Value (US$ Mn) Forecast, by Product, 2021 to 2031
Table 24: Europe Market Value (US$ Mn) Forecast, by Application, 2021 to 2031
Table 25: Europe Market Value (US$ Mn) Forecast, by Indication, 2021 to 2031
Table 26: Europe Market Value (US$ Mn) Forecast, by Vascular Diseases, 2021 to 2031
Table 27: Europe Market Value (US$ Mn) Forecast, by End User, 2021 to 2031
Table 28: Asia Pacific Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2021 to 2031
Table 29: Asia Pacific Market Value (US$ Mn) Forecast, by Product, 2021 to 2031
Table 30: Asia Pacific Market Value (US$ Mn) Forecast, by Venous Stents, 2021 to 2031
Table 31: Asia Pacific Market Value (US$ Mn) Forecast, by Catheters, 2021 to 2031
Table 32: Asia Pacific Market Value (US$ Mn) Forecast, by Product, 2021 to 2031
Table 33: Asia Pacific Market Value (US$ Mn) Forecast, by Application, 2021 to 2031
Table 34: Asia Pacific Market Value (US$ Mn) Forecast, by Indication, 2021 to 2031
Table 35: Asia Pacific Market Value (US$ Mn) Forecast, by Vascular Diseases, 2021 to 2031
Table 36: Asia Pacific Market Value (US$ Mn) Forecast, by End User, 2021 to 2031
Table 37: Latin America Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2021 to 2031
Table 38: Latin America Market Value (US$ Mn) Forecast, by Product, 2021 to 2031
Table 39: Latin America Market Value (US$ Mn) Forecast, by Venous Stents, 2021 to 2031
Table 40: Latin America Market Value (US$ Mn) Forecast, by Catheters, 2021 to 2031
Table 41: Latin America Market Value (US$ Mn) Forecast, by Guidewires, 2021 to 2031
Table 42: Latin America Market Value (US$ Mn) Forecast, by Application, 2021 to 2031
Table 43: Latin America Market Value (US$ Mn) Forecast, by Indication, 2021 to 2031
Table 44: Latin America Market Value (US$ Mn) Forecast, by Vascular Diseases, 2021 to 2031
Table 45: Latin America Market Value (US$ Mn) Forecast, by End User, 2021 to 2031
Table 46: Middle East & Africa Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2021 to 2031
Table 47: Middle East & Africa Market Value (US$ Mn) Forecast, by Product, 2021 to 2031
Table 48: Middle East & Africa Market Value (US$ Mn) Forecast, by Venous Stents, 2021 to 2031
Table 49: Middle East & Africa Market Value (US$ Mn) Forecast, by Catheters, 2021 to 2031
Table 50: Middle East & Africa Market Value (US$ Mn) Forecast, by Guidewires, 2021 to 2031
Table 51: Middle East & Africa Market Value (US$ Mn) Forecast, by Application, 2021 to 2031
Table 52: Middle East & Africa Market Value (US$ Mn) Forecast, by Indication, 2021 to 2031
Table 53: Middle East & Africa Market Value (US$ Mn) Forecast, by Vascular Diseases, 2021 to 2031
Table 54: Middle East & Africa Market Value (US$ Mn) Forecast, by End User, 2021 to 2031
List Of Figures
Figure 01: Global Market Value (US$ Mn) Forecast, 2021 to 2031
Figure 02: Global Market Value Share, by Product (2020)
Figure 03: Global Market Value Share, by Application (2020)
Figure 04: Global Market Value Share, by Indication (2020)
Figure 05: Global Market Value Share, by End User (2020)
Figure 06: Global Market Value Share, by Region (2020)
Figure 07: Global Market Value Share Analysis, by Product, 2021 and 2031
Figure 08: Global Market Value (US$ Mn), by Venous Stents, 2021 to 2031
Figure 09: Global Market Value (US$ Mn), by Catheters, 2021 to 2031
Figure 10: Global Market Value (US$ Mn), by Guidewires, 2021 to 2031
Figure 11: Global Market Value (US$ Mn), by Others, 2021 to 2031
Figure 12: Global Market Attractiveness Analysis, by Product, 2021 to 2031
Figure 13: Global Market Value Share Analysis, by Application, 2021 and 2031
Figure 14: Global Market Value (US$ Mn), by Leg, 2021 to 2031
Figure 15: Global Market Value (US$ Mn), by Chest, 2021 to 2031
Figure 16: Global Market Value (US$ Mn), by Abdomen, 2021 to 2031
Figure 17: Global Market Value (US$ Mn), by Arm, 2021 to 2031
Figure 18: Global Market Attractiveness Analysis, by Application, 2021 to 2031
Figure 19: Global Market Value Share Analysis, by Indication, 2021 and 2031
Figure 20: Global Market Value (US$ Mn), by Vascular Diseases, 2021 to 2031
Figure 21: Global Market Value (US$ Mn), by Cancer, 2021 to 2031
Figure 22: Global Market Attractiveness Analysis, by Indication, 2021 to 2031
Figure 23: Global Market Value Share Analysis, by End User, 2021 and 2031
Figure 24: Global Market Value (US$ Mn), by Hospitals, 2021 to 2031
Figure 25: Global Market Value (US$ Mn), by Specialty Clinics, 2021 to 2031
Figure 26: Global Market Value (US$ Mn), by Ambulatory Surgical Centers, 2021 to 2031
Figure 27: Global Market Value (US$ Mn), by Others, 2021 to 2031
Figure 28: Global Market Attractiveness Analysis, by End User, 2021 to 2031
Figure 29: Global Market Value Share Analysis, by Region, 2021 and 2031
Figure 30: Global Market Analysis, by Region
Figure 31: North America Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021 to 2031
Figure 32: North America Market Value Share (%), by Country, 2021 and 2031
Figure 33: North America Market Attractiveness, by Country, 2021 to 2031
Figure 34: North America Market Value Share Analysis, by Product, 2021 and 2031
Figure 35: North America Market Attractiveness, by Product, 2021 to 2031
Figure 36: North America Market Value Share Analysis, by Application, 2021 and 2031
Figure 37: North America Market Attractiveness, by Application, 2021 to 2031
Figure 38: North America Market Value Share Analysis, by Indication, 2021 and 2031
Figure 39: North America Market Attractiveness, by Indication, 2021 to 2031
Figure 40: North America Market Value Share Analysis, by End User, 2021 and 2031
Figure 41: North America Market Attractiveness, by End User, 2021 to 2031
Figure 42: Europe Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021 to 2031
Figure 43: Europe Market Value Share (%), by Countries/Sub-region, 2021 and 2031
Figure 44: Europe Market Attractiveness, by Countries/Sub-region, 2021 to 2031
Figure 45: Europe Market Value Share Analysis, by Product, 2021 and 2031
Figure 46: Europe Market Attractiveness, by Product, 2021 to 2031
Figure 47: Europe Market Value Share Analysis, by Application, 2021 and 2031
Figure 48: Europe Market Attractiveness, by Application, 2021 to 2031
Figure 49: Europe Market Value Share Analysis, by Indication, 2021 and 2031
Figure 50: Europe Market Attractiveness, by Indication, 2021 to 2031
Figure 51: Europe Market Value Share Analysis, by End User, 2021 and 2031
Figure 52: Europe Market Attractiveness, by End User, 2021 to 2031
Figure 53: Asia Pacific Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021 to 2031
Figure 54: Asia Pacific Market Value Share (%), by Countries/Sub-region, 2021 and 2031
Figure 55: Asia Pacific Market Attractiveness, by Countries/Sub-region, 2021 to 2031
Figure 56: Asia Pacific Market Value Share Analysis, by Product, 2021 and 2031
Figure 57: Asia Pacific Market Attractiveness, by Product, 2021 to 2031
Figure 58: Asia Pacific Market Value Share Analysis, by Application, 2021 and 2031
Figure 59: Asia Pacific Market Attractiveness, by Application, 2021 to 2031
Figure 60: Asia Pacific Market Value Share Analysis, by Indication, 2021 and 2031
Figure 61: Asia Pacific Market Attractiveness, by Indication, 2021 to 2031
Figure 61: Asia Pacific Market Value Share Analysis, by End User, 2021 and 2031
Figure 63: Asia Pacific Market Attractiveness, by End User, 2021 to 2031
Figure 64: Latin America Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021 to 2031
Figure 65: Latin America Market Value Share (%), by Countries/Sub-region, 2021 and 2031
Figure 66: Latin America Market Attractiveness Analysis, by Countries/Sub-region, 2021 to 2031
Figure 67: Latin America Market Value Share Analysis, by Product, 2021 and 2031
Figure 68: Latin America Market Attractiveness Analysis, by Product, 2021 to 2031
Figure 69: Latin America Market Value Share Analysis, by Application, 2021 and 2031
Figure 70: Latin America Market Attractiveness Analysis, by Application, 2021 to 2031
Figure 71: Latin America Market Value Share Analysis, by Indication, 2021 and 2031
Figure 72: Latin America Market Attractiveness Analysis, by Indication, 2021 to 2031
Figure 73: Latin America Market Value Share Analysis, by End User, 2021 and 2031
Figure 74: Latin America Market Attractiveness Analysis, by End User, 2021 to 2031
Figure 75: Middle East & Africa Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021 to 2031
Figure 76: Middle East & Africa Market Value Share (%), by Countries/Sub-region, 2021 and 2031
Figure 77: Middle East & Africa Market Attractiveness Analysis, by Countries/Sub-region, 2021 to 2031
Figure 78: Middle East & Africa Market Value Share Analysis, by Product, 2021 and 2031
Figure 79: Middle East & Africa Market Attractiveness Analysis, by Product, 2021 to 2031
Figure 80: Middle East & Africa Market Value Share Analysis, by Application, 2021 and 2031
Figure 81: Middle East & Africa Market Attractiveness Analysis, by Application, 2021 to 2031
Figure 82: Middle East & Africa Market Value Share Analysis, by Indication, 2021 and 2031
Figure 83: Middle East & Africa Market Attractiveness Analysis, by Indication, 2021 to 2031
Figure 84: Middle East & Africa Market Value Share Analysis, by End User, 2021 and 2031
Figure 85: Middle East & Africa Market Attractiveness Analysis, by End User, 2021 to 2031
- FAQs -
How will the market expand through 2031?
According to Fact.MR’s projections, the global venous procedure devices market is expected to post significant gains, reaching over US$ 3 billion by 2031, registering a CAGR of approximately 6% throughout the forecast period. Growth is largely influenced
Who are key players manufacturing venous procedure devices?
Medtronic Plc., Cardinal Health, Becton Dickinson & Co. (BD), Teleflex Incorporated, Terumo Corporation, Cook Medical, Abbott Laboratories, and B. Braun Melsungen AG are some prominent venous procedure device manufacturers profiled by Fact.MR.
Which is the most promising application area for venous procedure devices?
Venous procedure devices for vascular treatment will emerge as the dominant application area in forthcoming years
Will North America generate high revenue generation opportunities?
Yes. The North American market promises to emerge as the most promising landscape, attributed to a surging prevalence rate of peripheral arterial diseases across the United States
Related Reports
Venous Procedure Devices Market